PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Caroline Burgard

Saarland University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Organ and tumor dosimetry of [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC

European Journal of Nuclear Medicine and Molecular Imaging

First dosimetry characterization of 161Tb-PSMA-617 in a small, uncontrolled registry cohort without clinical outcome data, providing absorbed dose estimates but lacking efficacy, safety or comparative evidence.

PreliminaryCaroline Burgard Arne Blickle Prostate Cancer Treatment and Research

Reported

Sample size15

Number of tumor lesions43

Mean kidney absorbed dose0.70 ± 0.41 Gy/GBq

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support